Cargando…

Apolipoprotein B Is Related to Metabolic Syndrome Independently of Low Density Lipoprotein Cholesterol in Patients with Type 2 Diabetes

BACKGROUND: Increased low density lipoprotein cholesterol (LDL-C) level and the presence of metabolic syndrome (MetS) are important risk factors for cardiovascular disease (CVD) in type 2 diabetes mellitus (T2DM). Recent studies demonstrated apolipoprotein B (apoB), a protein mainly located in LDL-C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Younghyup, Yoo, Soyeon, Lee, Sang Ah, Chin, Sang Ouk, Heo, Dahee, Moon, Jae Cheol, Moon, Shinhang, Boo, Kiyoung, Kim, Seong Taeg, Seo, Hye Mi, Jwa, Hyeyoung, Koh, Gwanpyo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Endocrine Society 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508266/ https://www.ncbi.nlm.nih.gov/pubmed/26194080 http://dx.doi.org/10.3803/EnM.2015.30.2.208

Ejemplares similares

Factors Associated with Glycemic Variability in Patients with Type 2 Diabetes: Focus on Oral Hypoglycemic Agents and Cardiovascular Risk Factors
por: Yoo, Soyeon, et al.
Publicado: (2015)

Characteristics of Subjects with Very Low Serum Low-Density Lipoprotein Cholesterol and the Risk for Intracerebral Hemorrhage
por: Lee, Jae-Geun, et al.
Publicado: (2012)

Correlation of Glypican-4 Level with Basal Active Glucagon-Like Peptide 1 Level in Patients with Type 2 Diabetes Mellitus
por: Lee, Sang Ah, et al.
Publicado: (2016)

SUN-145 Factors Related to Blood Intact Incretin Levels in Patients with Type 2 Diabetes
por: Yoo, Soyeon, et al.
Publicado: (2019)

Association of Glucagon to Insulin Ratio and Metabolic Syndrome in Patients with Type 2 Diabetes
por: Bang, Jisun, et al.
Publicado: (2023)

A Case of Posterior Mediastinal Plasmacytoma Confounded by Community-Acquired Pneumonia
por: Heo, Dahee, et al.
Publicado: (2015)

Fasting and Postprandial Hyperglycemia: Their Predictors and Contributions to Overall Hyperglycemia in Korean Patients with Type 2 Diabetes
por: Moon, Jaecheol, et al.
Publicado: (2020)

Efficacy and Safety of High-Dose Atorvastatin in Moderate-to-High Cardiovascular Risk Postmenopausal Korean Women with Dyslipidemia
por: Moon, Jaecheol, et al.
Publicado: (2020)

Triglyceride-Rich Lipoproteins and Remnant Cholesterol in Cardiovascular Disease
por: Heo, Ji Hye, et al.
Publicado: (2023)

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
por: Sniderman, Allan D., et al.
Publicado: (2016)

The Change in Glucagon Following Meal Ingestion Is Associated with Glycemic Control, but Not with Incretin, in People with Diabetes
por: Yoo, Soyeon, et al.
Publicado: (2021)

Current Status of Low-Density Lipoprotein Cholesterol Target Achievement in Patients with Type 2 Diabetes Mellitus in Korea Compared with Recent Guidelines
por: Yun, Soo Jin, et al.
Publicado: (2022)

Factors Related to Blood Intact Incretin Levels in Patients with Type 2 Diabetes Mellitus
por: Yoo, Soyeon, et al.
Publicado: (2019)

The Effects of Apolipoprotein F Deficiency on High Density Lipoprotein Cholesterol Metabolism in Mice
por: Lagor, William R., et al.
Publicado: (2012)

Sugar-Sweetened Beverage Consumption and Plasma Lipoprotein Cholesterol, Apolipoprotein, and Lipoprotein Particle Size Concentrations in US Adults
por: Haslam, Danielle E, et al.
Publicado: (2022)

Effects of apolipoprotein A5 haplotypes on the ratio of triglyceride to high-density lipoprotein cholesterol and the risk for metabolic syndrome in Koreans
por: Cha, Seongwon, et al.
Publicado: (2014)

Clinical Evidence and Mechanisms of High-Protein Diet-Induced Weight Loss
por: Moon, Jaecheol, et al.
Publicado: (2020)

Association of the Apolipoprotein B/Apolipoprotein A-I Ratio, Metabolic Syndrome Components, Total Cholesterol, and Low-Density Lipoprotein Cholesterol with Insulin Resistance in the Population of Georgia
por: Makaridze, Zaza, et al.
Publicado: (2014)

Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes
por: Schmidt, Amand F., et al.
Publicado: (2023)

Relationship between non–high-density lipoprotein cholesterol/apolipoprotein A-I and monocyte/high-density lipoprotein cholesterol ratio and coronary heart disease
por: Li, Ya, et al.
Publicado: (2020)

Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk
por: Glavinovic, Tamara, et al.
Publicado: (2022)

Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol
por: Fonseca, Liliana, et al.
Publicado: (2020)

Apolipoprotein B is associated with CT-angiographic progression beyond low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in patients with coronary artery disease
por: Shui, Xing, et al.
Publicado: (2023)

Effect of Synthetic Truncated Apolipoprotein C-I Peptide on Plasma Lipoprotein Cholesterol in Nonhuman Primates
por: Kushwaha, Rampratap S., et al.
Publicado: (2004)

Effects of Red Grape Juice Consumption on High Density Lipoprotein-Cholesterol, Apolipoprotein AI, Apolipoprotein B and Homocysteine in Healthy Human Volunteers
por: Khadem-Ansari, Mohammad H, et al.
Publicado: (2010)

Identification of Sequence Variation in the Apolipoprotein A2 Gene and Their Relationship with Serum High-Density Lipoprotein Cholesterol Levels
por: Bandarian, Fatemeh, et al.
Publicado: (2016)

Reduced Serum Levels of Triglyceride, Very Low Density Lipoprotein Cholesterol and Apolipoprotein B in Parkinson’s Disease Patients
por: Wei, Qiang, et al.
Publicado: (2013)

High-density lipoprotein cholesterol as a predictor of clinical outcomes in patients achieving low-density lipoprotein cholesterol targets with statins after percutaneous coronary intervention
por: Seo, Suk Min, et al.
Publicado: (2011)

Effect of Evolocumab on Non‐High‐Density Lipoprotein Cholesterol, Apolipoprotein B, and Lipoprotein(a): A Pooled Analysis of Phase 2 and Phase 3 Studies
por: Toth, Peter P., et al.
Publicado: (2020)

Gestational hyperlipidemia and acute pancreatitis with underlying partial lipoprotein lipase deficiency and apolipoprotein E3/E2 genotype
por: Han, Dong Hee, et al.
Publicado: (2013)

The association between the apolipoprotein A1/ high density lipoprotein -cholesterol and diabetes in Taiwan — a cross-sectional study
por: Jian, Zhi-Hong, et al.
Publicado: (2013)

Apolipoprotein B is not superior to non-high-density lipoprotein cholesterol for dyslipidemic classification of glycated hemoglobin-defined diabetic patients
por: Xie, Junhui, et al.
Publicado: (2018)

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
por: Contois, John H., et al.
Publicado: (2023)

Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol‐Lowering Therapy
por: Chan, Dick C., et al.
Publicado: (2019)

A case of hepatic cyst-induced inferior vena cava thrombosis
por: Moon, Jaecheol, et al.
Publicado: (2014)

Circulating Lipoprotein Lipids, Apolipoproteins and Ischemic Stroke
por: Yuan, Shuai, et al.
Publicado: (2020)

Apolipoprotein E-associated Lipoprotein Glomerulo-tubulopathy
por: Tanimizu, Hikaru, et al.
Publicado: (2023)

Effects of Evolocumab on Low‐Density Lipoprotein Cholesterol, Non–High Density Lipoprotein Cholesterol, Apolipoprotein B, and Lipoprotein(a) by Race and Ethnicity: A Meta‐Analysis of Individual Participant Data From Double‐Blind and Open‐Label Extension Studies
por: Daviglus, Martha L., et al.
Publicado: (2020)

Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol
por: Zheng, Weili, et al.
Publicado: (2022)

High Density Lipoprotein and Its Precursor Protein Apolipoprotein A1 as Potential Therapeutics to Prevent Anthracycline Associated Cardiotoxicity
por: Kluck, George E. G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qspn370660uqoejiinfs5j2asm